These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 29723439)

  • 21. Analytical method development, identification, and characterization of stress degradation products of idelalisib by ultrahigh-performance liquid chromatography with photodiode array and ultrahigh-performance liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry studies.
    Mahesh M; Bali A; Gupta T
    Rapid Commun Mass Spectrom; 2024 Jun; 38(11):e9745. PubMed ID: 38591150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Forced degradation studies of lansoprazole using LC-ESI HRMS and
    Shankar G; Borkar RM; Suresh U; Guntuku L; Naidu VGM; Nagesh N; Srinivas R
    J Mass Spectrom; 2017 Jul; 52(7):459-471. PubMed ID: 28544042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
    Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability-Indicating Reversed-Phase UHPLC Method Development and Characterization of Degradation Products of Almotriptan Maleate by LC-QTOF-MS/MS.
    Saibaba B; Vishnuvardhan C; Johnsi Rani P; Satheesh Kumar N
    J Chromatogr Sci; 2018 Jan; 56(1):6-17. PubMed ID: 28977362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
    Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
    J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification, characterization, and in silico ADMET prediction of nirmatrelvir and its degradation products using HPLC-PDA and LC-QTOF-MS/MS.
    Kumar MA; Sundararajan R
    Rapid Commun Mass Spectrom; 2024 Oct; 38(20):e9896. PubMed ID: 39185574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of stress degradation products of duloxetine hydrochloride employing LC-UV/PDA and LC-MS/TOF studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Mar; 121():39-55. PubMed ID: 26775018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive study on degradation profile of firocoxib and structural elucidation of its key degradation products.
    Adhikari S; Tian J; Rustum AM
    J Pharm Biomed Anal; 2023 Feb; 224():115192. PubMed ID: 36463770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
    Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
    J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation, characterization using LC-ESI-QTOF, NMR and in vitro cytotoxicity assay of niclosamide forced degradation products.
    P J; Ch V; A L; V G M N; Ch N; N S
    J Pharm Biomed Anal; 2017 Mar; 136():148-155. PubMed ID: 28081501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of capmatinib degradation in stress conditions including degradation product characterization using ultra-high-performance liquid chromatography-quadrupole-time of flight mass spectrometry and stability-indicating analytical method development.
    Bhangare D; Rajput N; Jadav T; Sahu AK; Sengupta P
    Rapid Commun Mass Spectrom; 2023 Jan; 37(1):e9417. PubMed ID: 36226771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Forced degradation of fingolimod: effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF-MS/MS and 1H NMR.
    Patel PN; Kalariya PD; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2015 Nov; 115():388-94. PubMed ID: 26279369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Separation and characterization of related substances of Lurasidone hydrochloride by LC-QTOF-MS techniques.
    Siddig O; Liu C; Abdulbagi M; Song M; Lu YT; Hang TJ
    J Pharm Biomed Anal; 2024 Jan; 238():115834. PubMed ID: 37948773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of forced degradation products of canagliflozine by liquid chromatography/quadrupole time-of-flight tandem mass spectrometry and in silico toxicity predictions.
    Baira SM; Kalariya PD; Nimbalkar R; Garg P; Srinivas R; Talluri MVNK
    Rapid Commun Mass Spectrom; 2018 Feb; 32(3):212-220. PubMed ID: 29134712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LC-ESI-QTOF-MS analysis utilizing gas-phase fragmentation reactions subjected to ESI-IS-CID and ESI-CID-MS/MS conditions to study the degradation behaviour of sorafenib tosylate: NMR and in vitro cytotoxicity and apoptosis detection studies of hydrolytic degradation products.
    Johnsirani P; Wani AA; Bharatam PV; Nanjappan S
    J Pharm Biomed Anal; 2020 Jan; 177():112881. PubMed ID: 31542419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatographic separation of tiropramide hydrochloride and its degradation products along with their structural characterization using liquid chromatography quadrupole time-of-flight tandem mass spectrometry and nuclear magnetic resonance.
    Tidke M; Golla VM; Kushwah BS; Naik DD; Gananadhamu S
    Biomed Chromatogr; 2023 Aug; 37(8):e5636. PubMed ID: 37005769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural elucidation of major degradation products of milbemycin oxime drug substance using LC-MS and NMR.
    Adhikari S; Rustum AM
    J Pharm Biomed Anal; 2022 Aug; 217():114862. PubMed ID: 35662014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposal of degradation pathway with toxicity prediction for hydrolytic and photolytic degradation products of timolol.
    Devrukhakar PS; M SS; G S; R S
    J Pharm Biomed Anal; 2018 May; 154():7-15. PubMed ID: 29524771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of forced degradation products of tedizolid phosphate by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Lei Y; Jin B; Ma C; Zhang T; Li T
    J Pharm Biomed Anal; 2017 May; 139():221-231. PubMed ID: 28292681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability-indicating assay method for acotiamide: Separation, identification and characterization of its hydroxylated and hydrolytic degradation products along with a process-related impurity by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
    Thummar M; Patel PN; Samanthula G; Ragampeta S
    Rapid Commun Mass Spectrom; 2017 Nov; 31(21):1813-1824. PubMed ID: 28836303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.